# Deep Research Report: deep-research-pro-preview-12-2025
**Status:** ✅ Success | **Attempts:** 1/5 | **Run ID:** f1ce24d5 | **Time:** 280.61s | **Cost:** $1.28391
--------------------------------------------------------------------------------

# Intervention Thresholds and Cellular Autonomy in Nanorobot Swarm Control Architectures

### Key Points
*   **Gradient-Based Thresholds:** Intervention is frequently determined by detecting specific chemical gradients, such as the downregulation of E-cadherin (a cell adhesion molecule) or the upregulation of VEGF. A specific algorithmic protocol involves detecting a signal, verifying the gradient intensity, and employing a temporal wait state (e.g., 50 milliseconds) to filter out false positives before action is taken.
*   **Logic-Gated Activation:** DNA-based nanorobots utilize molecular logic gates (AND, OR, NOT) to establish intervention thresholds. Action is only triggered when multiple specific biomarkers (e.g., miRNA-21 and miRNA-125b) are simultaneously present, ensuring that healthy cells lacking the complete "disease signature" remain undisturbed.
*   **Biomimetic Signaling:** To respect cellular autonomy, advanced nanorobots mimic natural cellular communication. For instance, glucose-powered gold-silica nanorobots generate steady-state concentrations of hydrogen peroxide to signal cell migration rather than mechanically forcing it, integrating into the cell's natural homeostatic loops.
*   **Swarm Intelligence and Quorum Sensing:** Individual nanorobots often lack the processing power to determine complex thresholds. Instead, "quorum sensing" algorithms allow the swarm to intervene only when a critical density of agents confirms a pathological state, preventing sub-therapeutic interventions or toxic overdoses.

### Introduction
The integration of nanorobotics into biomedicine represents a paradigm shift from systemic treatment to cellular-level intervention. However, this precision necessitates a rigorous control architecture to ensure that artificial agents respect **cellular autonomy**—the inherent capacity of a cell to regulate its internal environment (homeostasis) and maintain its identity. Determining the "intervention threshold"—the precise set of conditions under which a nanorobot swarm transitions from passive surveillance to active therapeutic manipulation—is the central challenge in this field.

Research indicates that these thresholds are not static values but dynamic, multi-parametric calculations derived from chemical gradients, temporal verification protocols, and collective swarm decision-making. By utilizing biomimetic strategies, such as enzymatic logic and quorum sensing, nanorobots can distinguish between transient physiological fluctuations and pathological deviations, thereby preserving the autonomy of healthy tissue while effectively targeting disease.

---

## 1. Theoretical Framework: Cellular Autonomy and Nanorobotic Agency

To understand how intervention thresholds are determined, one must first define the operational constraints imposed by cellular autonomy. Biological autonomy is characterized by a system's ability to actively maintain its own organization (autopoiesis) and regulate its interaction with the environment [cite: 1]. In the context of nanomedicine, respecting this autonomy requires that nanorobots operate as non-disruptive observers until a specific pathological threshold is breached.

### 1.1 The Definition of Cellular Autonomy in Nanomedicine
Cellular autonomy implies that a cell possesses the "right" to self-determination regarding its metabolic and reproductive processes unless it poses a threat to the organism (e.g., carcinogenesis). Nanorobots are designed to act as "miniaturized surgeons" or "molecular patrols" [cite: 2, 3]. Their design philosophy often incorporates a variation of Asimov’s laws of robotics, specifically adapted for the nanoscale: a nanorobot must not injure the host (toxicity), must obey specific biochemical programming (targeting), and must eventually cease to exist (biodegradability) to prevent long-term interference with cellular processes [cite: 4].

### 1.2 The Conflict Between Intervention and Homeostasis
The fundamental tension in nanorobot control is distinguishing between homeostatic fluctuations and disease states. Cells naturally exhibit variance in protein expression, pH, and temperature. An intervention threshold must be sufficiently high to avoid "false positive" interventions that disrupt normal cellular function (violating autonomy) but sufficiently low to catch pathology before it becomes irreversible. For example, glucose-powered nanorobots have been developed to generate a steady-state concentration of hydrogen peroxide ($H_2O_2$) that mimics natural signaling. This approach respects cellular autonomy by using the cell's own communication language to guide behavior (e.g., migration) rather than overriding it with external force [cite: 5, 6].

---

## 2. Chemical Gradient Analysis and Signal Intensity Thresholds

The primary method for determining intervention thresholds involves the detection and analysis of chemical gradients. Nanorobots are equipped with nanosensors capable of detecting specific biomarkers. The decision to intervene is often algorithmic, based on the intensity and persistence of these chemical signals.

### 2.1 The E-cadherin Protocol
A definitive model for intervention thresholds is found in the detection of tumor cells via E-cadherin levels. E-cadherin is a transmembrane protein responsible for cell-cell adhesion; its downregulation is a hallmark of the epithelial-to-mesenchymal transition (EMT), a precursor to metastasis [cite: 7].

Research by Cavalcanti, Hogg, and colleagues has established a specific control algorithm for this biomarker:
1.  **Signal Detection:** The nanorobot monitors the concentration intensity of E-cadherin signals in the bloodstream or interstitial fluid [cite: 8, 9].
2.  **Gradient Following:** Upon detecting a signal anomaly (e.g., a sharp gradient indicating a tumor boundary), the nanorobot switches to a tracking mode [cite: 8, 10].
3.  **The 50ms Verification Threshold:** To respect cellular autonomy and avoid reacting to noise, the algorithm includes a temporal threshold. If the gradient estimate subsequent to the initial detection finds no additional signal within **50 milliseconds**, the nanorobot classifies the initial signal as a false positive. It aborts the intervention and continues to flow passively with the fluid [cite: 8, 10].

This 50ms wait-state is a critical "intervention threshold." It ensures that the nanorobot does not attack a cell based on a fleeting or stochastic fluctuation in biomarker levels, thereby preventing accidental damage to healthy cells.

### 2.2 Signal Intensity and False Positives
The intervention threshold is also defined by the **Signal-to-Noise Ratio (SNR)**. In intracellular environments, background chemical noise is high. Swarms of nanorobots can improve the SNR by aggregating at the site of interest. For instance, magnetic fluorescent nanoparticles can be manipulated to form a swarm inside a cell, increasing the local signal intensity by an order of magnitude compared to individual particles [cite: 11, 12]. The intervention is triggered only when the collective signal intensity exceeds the background noise by a statistically significant margin, ensuring that the "diagnosis" is accurate before any "treatment" (intervention) occurs.

### 2.3 Multi-Marker Detection (Multiplexing)
To further refine the intervention threshold and reduce error, nanorobots are designed to detect multiple markers simultaneously. A nanorobot might be programmed to intervene only if it detects Anti-EGFR (lung cancer marker) OR Anti-CEA (colon cancer marker) [cite: 13]. More complex thresholds involve **AND** logic (discussed in Section 4), where intervention occurs only if *both* markers are present, significantly narrowing the criteria for engagement and protecting cells that might express only one marker benignly.

---

## 3. Swarm Intelligence and Collective Decision-Making

Individual nanorobots are limited in size and computational power. Therefore, intervention thresholds are often determined collectively by the swarm. This "swarm intelligence" allows for emergent decision-making that respects cellular autonomy by ensuring that interventions are consensus-based rather than idiosyncratic.

### 3.1 Quorum Sensing and Density-Dependent Activation
Inspired by bacterial behavior, nanorobot swarms utilize **quorum sensing** to determine intervention thresholds. In this model, an individual nanorobot does not intervene upon detecting a target. Instead, it releases a secondary signaling molecule (an "attractant") to recruit other nanorobots [cite: 8, 10].

*   **The Threshold:** The intervention is triggered only when the local density of nanorobots ($N$) exceeds a critical threshold ($N_{critical}$).
*   **Mechanism:** This ensures that a sufficient dose of the therapeutic agent is available to be effective. Releasing a drug with only one nanorobot might be sub-therapeutic (ineffective) or trigger drug resistance. Conversely, waiting for a quorum ensures a coordinated, massive release that overwhelms the target [cite: 14].
*   **Autonomy Preservation:** By requiring a quorum, the system filters out isolated false positives. If a single nanorobot erroneously attaches to a healthy cell, it will not attract a quorum, and thus no intervention (drug release) will occur, sparing the healthy cell [cite: 15].

### 3.2 Decentralized Control and Emergence
Swarm control is decentralized; there is no "leader" robot. The intervention threshold emerges from the local interactions of thousands of agents. For example, in "active matter" research, particles individually lack intelligence, but collectively they can respond to environmental confinement or chemical gradients [cite: 15]. In cancer therapy, a "carriers-to-swarms" strategy is employed where nanorobots are transported in a protective carrier and released only upon reaching the tumor microenvironment. The swarm then collectively penetrates the tumor, guided by the physical and chemical properties of the tissue (e.g., enhanced permeability and retention effect) [cite: 16].

### 3.3 Acoustic and Chemical Communication
To coordinate these collective thresholds, nanorobots must communicate.
*   **Acoustic Communication:** Feasible for distances around 100 microns, acoustic signals allow nanorobots to broadcast their status (e.g., "Target Found") to neighbors. Frequencies between 10MHz and 300MHz are optimal for this scale [cite: 17, 18].
*   **Chemical Communication:** Nanorobots release specific molecules to create artificial gradients. A nanorobot that identifies a tumor cell in a small venule uses these signals to guide the rest of the swarm, improving the "intervention time" and ensuring the swarm focuses on the malignancy rather than drifting aimlessly [cite: 8, 9].

---

## 4. Biochemical Logic Gates: The "If-Then" of Cellular Intervention

At the molecular level, intervention thresholds are hard-coded into the nanorobot's structure using DNA origami and aptamer-based logic gates. This represents the most rigorous method of respecting cellular autonomy, as the robot is physically incapable of intervening unless the specific molecular keys are present.

### 4.1 DNA Logic Gates (AND, OR, NOT)
DNA nanorobots can be programmed with Boolean logic. A classic example is the "AND" gate used for precise tumor targeting.
*   **The Threshold:** The nanorobot is a closed cage containing a therapeutic payload (e.g., antibodies or toxins). The cage is locked by DNA aptamers that recognize specific cell-surface antigens or intracellular miRNAs.
*   **Mechanism:** The cage opens *only* if it detects **Biomarker A** AND **Biomarker B** simultaneously. For example, a study demonstrated a DNA nanorobot that detects both **miR-21** and **miR-125b** (tumor-associated microRNAs). The drug is released only when both are present, effectively distinguishing a cancer cell from a healthy cell that might express only one of these markers at low levels [cite: 4, 19].
*   **Respecting Autonomy:** This logic gate acts as a strict intervention threshold. A healthy cell that lacks one of the keys is physically invisible to the nanorobot, ensuring its autonomy is completely respected.

### 4.2 Aptamer-Encoded Reconfiguration
These nanorobots can reconfigure their structure upon crossing the threshold. For instance, a DNA nanorobot might exist in a "closed" (inert) state while circulating. Upon binding to the target threshold (specific protein concentration), it undergoes a conformational change to an "open" (active) state, exposing the drug payload [cite: 4]. This "conditional activation" is the physical embodiment of an intervention threshold.

---

## 5. Biomimetic Strategies and Metabolic Integration

Respecting cellular autonomy often means integrating with the cell's existing metabolic processes rather than disrupting them. This involves using endogenous fuel sources and signaling molecules.

### 5.1 Steady-State Signaling (The $H_2O_2$ Model)
Recent advancements have led to the development of glucose-powered gold-silica ($Au-SiO_2$) nanorobots. These devices do not merely dump drugs; they participate in cellular signaling.
*   **The Mechanism:** The nanorobots use glucose oxidase (GOx)-like activity to convert glucose into hydrogen peroxide ($H_2O_2$). Simultaneously, they catalyze the decomposition of $H_2O_2$.
*   **The Threshold:** By balancing synthesis and decomposition, the nanorobots maintain a **steady-state concentration** of $H_2O_2$.
*   **Autonomy:** This steady-state mimics natural cellular signaling pathways. The $H_2O_2$ acts as a chemotactic signal, inducing cell migration or proliferation in a controlled manner [cite: 5, 6]. Instead of a binary "attack" threshold, this represents a "modulation" threshold, where the nanorobot gently nudges the cell's behavior using the cell's own metabolic language.

### 5.2 Energy Scavenging and Metabolic Impact
Nanorobots often power themselves using glucose and oxygen found in the bloodstream [cite: 17, 20]. To respect cellular autonomy, the energy consumption of the swarm must remain below a threshold that would cause metabolic distress to the host cell.
*   **Glucose Thresholds:** Nanorobots (like "respirocytes" or "microbivores") consume endogenous serum glucose. The design specifications ensure that their consumption rate is negligible compared to the organism's baseline metabolism, preventing hypoglycemia or cellular starvation [cite: 21, 22].
*   **Biocompatibility:** The byproducts of this power generation (e.g., water and oxygen from $H_2O_2$ decomposition) must be non-toxic. Gold-anchored cerium oxide nanoparticles are used to facilitate the safe conversion of $H_2O_2$ to water, ensuring the intervention does not create oxidative stress that violates cellular integrity [cite: 23].

---

## 6. Environmental and Physical Triggers

Beyond chemical markers, intervention thresholds are often determined by the physical properties of the pathological environment.

### 6.1 Hypoxia Targeting
Tumor environments are often hypoxic (low oxygen) due to rapid growth outstripping blood supply.
*   **The Threshold:** Nanorobots can be designed to release their payload only when the local oxygen partial pressure ($pO_2$) falls below a specific level.
*   **Mechanism:** Magneto-aerotactic bacteria-based nanorobots naturally migrate toward hypoxic regions. Upon reaching these low-oxygen zones (the threshold), they release drug-filled nanoliposomes [cite: 24, 25]. This ensures that cytotoxic drugs are released only inside the tumor core, sparing oxygen-rich healthy tissues.

### 6.2 pH and Temperature Gradients
Pathological tissues often exhibit acidosis (low pH) or elevated temperatures (inflammation).
*   **pH Threshold:** Nanorobots with pH-sensitive coatings can remain stable at physiological pH (7.4) but degrade and release drugs at the acidic pH of a tumor microenvironment (e.g., pH 6.5) [cite: 2].
*   **Thermal Threshold:** Near-infrared (NIR) light can be used to heat nanorobots. The intervention threshold is determined by an external controller or the local accumulation of nanorobots. For example, Janus mesoporous silica nanorobots use NIR to generate a heat gradient for propulsion and drug release, minimizing invasive mechanical interaction with the cell membrane [cite: 2, 16].

---

## 7. Safety Protocols and Termination (The "Kill Switch")

A critical component of determining intervention thresholds is determining when *not* to intervene, or when to cease intervention. This is codified in the safety protocols that govern nanorobot lifecycles.

### 7.1 Asimov’s Laws for Nanomedicine
Theoretical frameworks for nanorobotics often cite a variation of Asimov’s laws:
1.  **Do Not Injure:** Nanorobots must be biocompatible and non-toxic [cite: 4].
2.  **Obey Programming:** They must follow the specific chemical gradients and logic gates defined above.
3.  **Self-Termination:** Unlike macro-robots, nanorobots must *not* preserve their own existence indefinitely. The "Third Law" for nanobots is that they must disintegrate into harmless byproducts once their task is complete [cite: 4].

### 7.2 Biodegradability as a Threshold
The ultimate respect for cellular autonomy is the complete removal of the intervention agent. Nanorobots are often constructed from biodegradable materials (e.g., DNA, proteins, or transient metals). The "termination threshold" is reached when the drug payload is exhausted or when a specific time has elapsed, triggering the breakdown of the bot into renal-clearable components [cite: 4, 26].

---

## 8. Conclusion

The determination of intervention thresholds for nanorobot swarms is a sophisticated process that blends molecular biology, control theory, and swarm intelligence. It is not a single value but a dynamic decision matrix.

*   **Chemical Precision:** Algorithms like the "E-cadherin 50ms verification" provide robust protection against false positives.
*   **Logical Rigor:** DNA AND-gates ensure that only cells matching a complex disease profile are targeted.
*   **Collective Wisdom:** Swarm density thresholds (quorum sensing) prevent ineffective or erratic individual actions.
*   **Metabolic Harmony:** Biomimetic signaling ($H_2O_2$ steady states) allows nanorobots to guide cellular behavior without violating the cell's autonomous control systems.

By adhering to these multi-layered thresholds, nanorobot swarms can function as effective therapeutic agents while strictly respecting the autonomy and integrity of the cellular environment they inhabit.

---

### References
*   **[cite: 24]** IGMIN Research, "Surgical nanorobotics and targeted cancer therapy."
*   **[cite: 14]** IEEE/ASME Transactions, "Overview of Micro/Nanorobot Swarm Control."
*   **[cite: 11]** ACS Nano, "Swarm control and intracellular measurements."
*   **[cite: 12]** ACS Nano, "Intracellular measurement using microrobotic swarms."
*   **[cite: 5]** PMC, "Glucose-powered Au-SiO2 nanorobots and H2O2 signaling."
*   **[cite: 2]** MDPI, "Nanorobots as miniaturized surgeons."
*   **[cite: 3]** ResearchGate, "Autonomous Nanorobots for Intracellular Applications."
*   **[cite: 4]** ACS Sensors, "Autonomous DNA nanorobots and logic gates."
*   **[cite: 8]** IEEE ICARCV, "Nanorobot Communication Techniques: E-cadherin and gradients."
*   **[cite: 17]** IEEE Transactions on NanoBioscience, "Acoustic Communication for Medical Nanorobots."
*   **[cite: 18]** Arxiv, "Coordinating microscopic robots."
*   **[cite: 1]** ResearchGate, "Organizational requirements for multicellular autonomy."
*   **[cite: 25]** 311 Institute, "Nanorobots targeting hypoxic tumor regions."
*   **[cite: 16]** ResearchGate, "Minimizing nanorobot swarm loss."
*   **[cite: 15]** Technology Networks, "Swarm intelligence and active matter."
*   **[cite: 27]** ResearchGate, "Response-threshold method for early cancer diagnosis."
*   **[cite: 19]** PMC, "Micro-/nanorobots for cancer diagnosis and treatment."
*   **[cite: 13]** HubXchange, "Nanorobotics in cancer detection (12 types)."
*   **[cite: 6]** Telight, "Glucose-powered nanorobots and biomimicry."
*   **[cite: 23]** PMC, "Glucose-Enhanced Nanorobot Diffusion."
*   **[cite: 4]** ACS Sensors, "Asimov's laws and nanorobot safety."
*   **[cite: 9]** Semantic Scholar, "Nanorobot Communication Techniques."
*   **[cite: 8]** SciSpace, "Nanorobot Communication Techniques (Tutorial)."
*   **[cite: 10]** NanorobotDesign, "Cancer detection and E-cadherin."
*   **[cite: 7]** PMC, "CTC detection and E-cadherin downregulation."
*   **[cite: 22]** ResearchGate, "Nanorobots in drug delivery systems."

**Sources:**
1. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE4IhyO9SXQj8YS8GcxooyEqH3-jFZnvRREkjDBBCJPNRuwxawxvKFqj8aQCnQ03CfUYAieUTu_Sa6AGs_ZncBcEQE9R98CspJveyRHJ-4TBGuTduX4tp2bntcEr20wmuBOEwU-Gb9mI4cJAhxiJdlTUrviPK4ccHRDzC5VCHQo4PW4Buz_ulnCN1aylHRa3h6NvdQI6d-wrcRt_ai1H_eRE4nBdG6zWxCrspw82wNyq17wf5XD-9bdR_K8Rw9_TM-stwc6ww9O)
2. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF0kdyg_zgdzzAA2MomPjHnsPdBV1zcT5bKs1UHnPFM9nATkLZnrOtTvdXAil5A-vuzL3D8AzmOd8uUObSUlpCizYXyeU1wzfY1PruTSuWpJ4rW7eBLJq3W2yIuRrI=)
3. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFWnYGWMoMngkc3X6KN9C2BkuKIXy7pI1UK63k0150VSavTSYkxzlyZTtqKPJp6OdXvINFCkUqp0uNJP75cilvD3pvQeRuKDNpOVAVUoFWYzLo3fgzC2riUtnleMOOP484u4ffIGP5IO6hZuYR1dSdNsJmB0p5JMaDUum3I-IWGZbNQyXOtQMDAQqzWIbB51ULoqIxd5kPxzoFjMOwsjKhIma2l1loAGRac7pZiHiyzADu1os5aWPo=)
4. [acs.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1RG-wmYnVcADD__S90f9uEHPdfkXPNUAm6E6xkjC5WuKrwwqL06o_K-cefrGOeKd2B6km9oDa0jAB7o3_S2vDMengr9UMnB3XtuTbU-STJ21KL8icQypFObqxolUaYFSMid5wgdP7UuM=)
5. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEOIK1tydhWFMTbG6dAAmWJ-Nbs6aDVp0C3YJtxw1JvChC362qduW_ZqPqe86smEuhQeDL7ZdsoQyECSrsFizcRukc-Qmtj85RHu0gTXDNwlqjscITIujlhpDL2nhazmf7JRotRBwggLQ==)
6. [telight.eu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE6YSPXeL6JBiV4tjiNhkON0NeYXPOfJ7wfEwttF_rc_xqXSt2vN_RZv0sM4lt2BfWrSHFmcIQg8lRR39ECI2OoFiQTCXu95MBMR1CrzZmqb26OC8iH0qwtc_iOkKluc3fYLiy1)
7. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGfrpmWLFTr0Nbj3XXibKTA5atuBidZbZP3OaBKZCxtgNqO4SDsb9PDCDMl7OWMvMezUwXPwFYZTZYsBGNtkhqgBy6_PO7euP_1vCqi13QYWq3SAQAzdP7WrQHl09WmVi609IGd1eqV)
8. [scispace.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmzZFY9DLx1TWJ2-KuEJGM2mmj7T_XFQt0HsFAThH1B7d9EoNmlAGyojctD8X1EuDaHR1DGd3dziTgrIiEC2WrQTPbMtUzgushem-66236oPGAjV1XE0NRnZP15YeO1119pPSHwbM89AMYvEEOrc6U62caWiBRAuDS2qGVw47t2CvltyLppqbg7KDp_7SuLs9dPKqwxr1O8lQ=)
9. [semanticscholar.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGAMzU2l0DUYqw9cBAFKIVhNBX2rpgRxRUf4WUCqF7lHHln0qzcvkUVp5YDyK5mv3UHrKM05l467Ae9_ijtePZz-lfLnz1TzkNF4wS3XnNownldOc_78C04GNqpuKZYIjjAkS0mk3FXBh7V2heMdQYKBEWkF2vE1ZaKC9IeX-NtRQilWzcLA3UrxO8FtZueD2XG6mgE8xUszTflmKoMK-s5G-ygW1OaX0XsBidJxto0-r8PqqWt3Y3M2z-ZXfPmgQDHQj496VqzD11amw==)
10. [nanorobotdesign.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG_BNiaZ_BiP_IpbJ5AkpKUPZbbLN0KLRJU44rNZquboayTNdBzFOx9RaC6gLGOsGUU5TXjdAru3eiNC6eiRHN3rFoO4GUJjYCRaCTWq4P0BGM6zXM4VSIFDo20SzQ80Eld_UYQwYA=)
11. [acs.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEMmYxyuEPePyQ1p2DdGH4RqNSWLNHSryOuGXh2zEeEuRfMWsXqHQBk-9UDSEb_C4J2bAYhZWWf7Rj2UDk8u6XuZvNV0324NllVitbZyRPljFZ2i5aJswwNThjeoXlDXdVdmVosapw=)
12. [utoronto.ca](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHtq8aoCqKExb89FCMJzi66SEyjg7pEHJjHhGYbbDEFsMIrJP2QaViuXMW7rhZ8i77dFSV6LRK4_9GftKYlB913ptksedGnXY0dsEHyRQju0jVc4bdWgkgRV2t1HMbZZBRtAr3MzWfFcTAvopXOcPtvACn9RoUaeRkCahQqoA==)
13. [hub-xchange.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQED7GE48S1WOZoFpuejRIc92iwq16wiDt7rZERzRXTicU_0u1fXFHRe1JCD7LD8ZFOxHhZALANVdtTSeu_pKOtyGvZ-OO9Ur3yN_Yb0utNpTRVlqLN0s0YaU-mnxnE1JLtkpPXgkjed33XVwwVk0tUuV0KOQ48BKukgUtD8lvRpagTmXQsl9Zu9mzXVvnM_tx-dhE16KBea9uyEbB3FbQBbwu2dm6HrCb8FHw==)
14. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFqtmpTs-1LtCMEExBhTOcXGvWxvkHdFWSp5K63xvs0h6ZGgDrbzVN-LG5XYOhL1w1nsDsOpARwbg20D9haSU3caip36P4M4van_2ltIL5gNmxmFCFwWeqoEDzT-ODyzGkhU18aldKgYhZ9vEUk_7cIIdM3NjN3UQt69x6PDipsQYsyg9YKDqv8WbsXIq-2D09j2jwDOpw0N0M-ZJZw17gIO631TNrNgsGT3JMMXRqE-C9EirHafI23bd3qmvvO8jg=)
15. [technologynetworks.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEyx6ylM7ficknZ1XetcZ0bA9det8CXMCWWfs00M88W5jMhPsozzihQMs4JbY3aA0mNQ6d3db3RcKhdKJK9ikYrU6eQ_M_EtLKEHtwfl_VJjuqaD9polfE5sWsDV0ctpBphVCX6YDgh8kOIJlLfy1W0mqQhwNiS6CFe_6Xy_XXnVGP38xnNB_W1MWPzijUjLa6x9-F1WnT5gT6sg05AOa0bZ7eqaFbx95m31w==)
16. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHqKu155n_JzPsxpDjQGmYDoYu_dQ_l91AEqLv_-4bV596p3_ItlokeWSVZ39QLmmOX87sI7aiDeehGyKued2L3aaHe_wKoetTv332726NoZhyZHPSX8IN3ccmShMUZwdvhqmHxemhYB-34hRkOS4QIA7eI7lZXATmai3kOJoDnvaBKDS17jUYPRt4FLKJFP0LGRbODJRL8YIPRAbkQKcTiVNHMm1Qf_Yi3wOuEoi9kIjcL0dir15mkWsetp7Z8E7aW)
17. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEtdksKa0dUvs7kStF8tucfQ87VJYu3xdxYxhXkU6F0eTgexnTO7BU4V2zv0tNxtLY3U10BFB7ZIRkpgdwey4YJwjsttEqigSRorx1FoFrO9Q8S9HM1GjnyZnNwobyF6pLuqhOZcK6YJ1LAom2FGlb-X7GpuH5oq5rMaHWdqRfjzUC3mcEQXg1shJEQRwruTF2ugP8KjK4=)
18. [arxiv.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHbLQbl12LRpEGi6I1NPwXo8HAygQvf-dfqTo0YWbTTAWchm4nGCqp0AQjRooDm1lL1nwDwc9PlTSEln4hiOyvj4bAsa4XlqnT1kYTBGpwg14fIJBID)
19. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGcR1diqfoZt22UFDiRqyV0UqADeAX5V_Y0d_HJZKgtrxJhJ0JJSRCdBTdGAj8cnavVwCNS0PvHSp8-xInGWYUJQtBL4sXzxwHEx9XD7v77_pkRN4LFL70HIn8Lzx5kXquppMikeE7NcA==)
20. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQElIXNqcyfdqCMThhsQBzzTAWr9nTxu0XCSwqphUa2uOHkqfTJB67TLm8fp1ZQTNymBvzPLJ0DfBK1rWJbR9OrVzxsco-y4DnfhG_CvY4MXbfgZrvN5nwepSm-7RoVKYDgF1C-Vpk9n)
21. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF8D3g-Ypz8qaH1BAjHKGpy5qiU6m0mXh0SyXMaC7nY0mc-Mok0mH020IKkYSFVJl9N68gf0qG9J6QpxSKKdkTROx6Gi9S4RkfKK0mR9_oo1qImSBC-nMZ0RjVTgI_3R3y4L1rFUXgJpA==)
22. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH7zeaiexw1RJ4I07pyU_ueNkbZBihma1F7Z1_Ax12C6X_nAuQeHmk_muCzQ76KS38mEGIEQvgXmjfkmzksJiDih5dYON1wuDexNlFa5ULW2oXYgpcwe1LCTADM_SoWJfbsb4thr5fWftLmJav8rjXurVSyo8GD_db9K3eBLTU7DWJHAZ_4ZzqTTYadr9Yv7YXPbwLCrYA2b-jITuj0SN8bblGOnw==)
23. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEfdMSaOt-CZtHFuJ5w8Q059tEeq_Q_pC51cTT5zGURl-Ybho1REB4JhQeghURGjvQ6MtBVT-SxxsReO_Zq8hSenMjY0m12HRy_PtLhBjwYCozuTxPQwXgFe85HHSfej7LoWJJKme7egg==)
24. [igminresearch.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEHJnqxSCjRMIC31h4Aip_tLZCkozyoCUv37MSMDjLjChpxlpBwPCR2YIEXVNR8FdK2Mws3OeG2zyuQh89IWB2juBuWG6W17hSyWLW0yiM7hVeJCGZRCrQUbBuLiLOTdLiRV3Kq_8ZOz27fW32kEg4=)
25. [311institute.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH1hPnCcTjKGai9TTP1dUrAZ7AORiIILYXufn8OuZurPf_wYkBRxrjjzLMjxs0K-PwsnxRN33r8HtK4omi8VLMpUY5NW7G0TT_2SxFcOyt2WuUwwPXqhwS5ji9JFXJ7xVwsmUhjrNyBmbZzk1Fud5uF_hSRBdWuq_jI7oopUs621ivuVhH0EXmJVRccLLtn9sA=)
26. [gamma.site](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHfonUhG1Yc8ZVfB2f4hV6Ewyfoprk_LRio_zmINVAhxshSder8DAeDCX2aEw67VjwF0CPAVInNDGS7dFyFyhbivnPQDoIbHNR_IWzkVg6oaBukpEqUzc5-QMoyEPa0KSM6mhhMR6GvRCo3)
27. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHPSm_HDTP6wqI767e01X1iBAUsuBgSjQI_hajuekNJO4RIq7XuOVctZbaeLt6IB7RHlm9icm367zgAkQroXv8zsXmtbVBkdoi_v_-ounDSWSsnLjldaV9CrONRbEyNUxEzOgfpulr71f5l_xvSr0UkAP_Gjuho5ygY4LJi2RV-kS-0-tshxR4BnOF_rhfiNlPQLcrx2_Ew13FbkuzMit5zVletoskT2N0AfXKFQUYZZXPtaOGNtB6h-6pScRd3hkp0-fuAeCwjKg==)


## Annotations
Annotation(end_index=3028, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE4IhyO9SXQj8YS8GcxooyEqH3-jFZnvRREkjDBBCJPNRuwxawxvKFqj8aQCnQ03CfUYAieUTu_Sa6AGs_ZncBcEQE9R98CspJveyRHJ-4TBGuTduX4tp2bntcEr20wmuBOEwU-Gb9mI4cJAhxiJdlTUrviPK4ccHRDzC5VCHQo4PW4Buz_ulnCN1aylHRa3h6NvdQI6d-wrcRt_ai1H_eRE4nBdG6zWxCrspw82wNyq17wf5XD-9bdR_K8Rw9_TM-stwc6ww9O', start_index=3019)
Annotation(end_index=3553, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF0kdyg_zgdzzAA2MomPjHnsPdBV1zcT5bKs1UHnPFM9nATkLZnrOtTvdXAil5A-vuzL3D8AzmOd8uUObSUlpCizYXyeU1wzfY1PruTSuWpJ4rW7eBLJq3W2yIuRrI=', start_index=3541)
Annotation(end_index=3553, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFWnYGWMoMngkc3X6KN9C2BkuKIXy7pI1UK63k0150VSavTSYkxzlyZTtqKPJp6OdXvINFCkUqp0uNJP75cilvD3pvQeRuKDNpOVAVUoFWYzLo3fgzC2riUtnleMOOP484u4ffIGP5IO6hZuYR1dSdNsJmB0p5JMaDUum3I-IWGZbNQyXOtQMDAQqzWIbB51ULoqIxd5kPxzoFjMOwsjKhIma2l1loAGRac7pZiHiyzADu1os5aWPo=', start_index=3541)
Annotation(end_index=3908, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1RG-wmYnVcADD__S90f9uEHPdfkXPNUAm6E6xkjC5WuKrwwqL06o_K-cefrGOeKd2B6km9oDa0jAB7o3_S2vDMengr9UMnB3XtuTbU-STJ21KL8icQypFObqxolUaYFSMid5wgdP7UuM=', start_index=3899)
Annotation(end_index=4731, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE6YSPXeL6JBiV4tjiNhkON0NeYXPOfJ7wfEwttF_rc_xqXSt2vN_RZv0sM4lt2BfWrSHFmcIQg8lRR39ECI2OoFiQTCXu95MBMR1CrzZmqb26OC8iH0qwtc_iOkKluc3fYLiy1', start_index=4719)
Annotation(end_index=4731, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEOIK1tydhWFMTbG6dAAmWJ-Nbs6aDVp0C3YJtxw1JvChC362qduW_ZqPqe86smEuhQeDL7ZdsoQyECSrsFizcRukc-Qmtj85RHu0gTXDNwlqjscITIujlhpDL2nhazmf7JRotRBwggLQ==', start_index=4719)
Annotation(end_index=5457, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGfrpmWLFTr0Nbj3XXibKTA5atuBidZbZP3OaBKZCxtgNqO4SDsb9PDCDMl7OWMvMezUwXPwFYZTZYsBGNtkhqgBy6_PO7euP_1vCqi13QYWq3SAQAzdP7WrQHl09WmVi609IGd1eqV', start_index=5448)
Annotation(end_index=5722, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmzZFY9DLx1TWJ2-KuEJGM2mmj7T_XFQt0HsFAThH1B7d9EoNmlAGyojctD8X1EuDaHR1DGd3dziTgrIiEC2WrQTPbMtUzgushem-66236oPGAjV1XE0NRnZP15YeO1119pPSHwbM89AMYvEEOrc6U62caWiBRAuDS2qGVw47t2CvltyLppqbg7KDp_7SuLs9dPKqwxr1O8lQ=', start_index=5710)
Annotation(end_index=5722, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGAMzU2l0DUYqw9cBAFKIVhNBX2rpgRxRUf4WUCqF7lHHln0qzcvkUVp5YDyK5mv3UHrKM05l467Ae9_ijtePZz-lfLnz1TzkNF4wS3XnNownldOc_78C04GNqpuKZYIjjAkS0mk3FXBh7V2heMdQYKBEWkF2vE1ZaKC9IeX-NtRQilWzcLA3UrxO8FtZueD2XG6mgE8xUszTflmKoMK-s5G-ygW1OaX0XsBidJxto0-r8PqqWt3Y3M2z-ZXfPmgQDHQj496VqzD11amw==', start_index=5710)
Annotation(end_index=5893, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmzZFY9DLx1TWJ2-KuEJGM2mmj7T_XFQt0HsFAThH1B7d9EoNmlAGyojctD8X1EuDaHR1DGd3dziTgrIiEC2WrQTPbMtUzgushem-66236oPGAjV1XE0NRnZP15YeO1119pPSHwbM89AMYvEEOrc6U62caWiBRAuDS2qGVw47t2CvltyLppqbg7KDp_7SuLs9dPKqwxr1O8lQ=', start_index=5880)
Annotation(end_index=5893, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG_BNiaZ_BiP_IpbJ5AkpKUPZbbLN0KLRJU44rNZquboayTNdBzFOx9RaC6gLGOsGUU5TXjdAru3eiNC6eiRHN3rFoO4GUJjYCRaCTWq4P0BGM6zXM4VSIFDo20SzQ80Eld_UYQwYA=', start_index=5880)
Annotation(end_index=6307, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmzZFY9DLx1TWJ2-KuEJGM2mmj7T_XFQt0HsFAThH1B7d9EoNmlAGyojctD8X1EuDaHR1DGd3dziTgrIiEC2WrQTPbMtUzgushem-66236oPGAjV1XE0NRnZP15YeO1119pPSHwbM89AMYvEEOrc6U62caWiBRAuDS2qGVw47t2CvltyLppqbg7KDp_7SuLs9dPKqwxr1O8lQ=', start_index=6294)
Annotation(end_index=6307, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG_BNiaZ_BiP_IpbJ5AkpKUPZbbLN0KLRJU44rNZquboayTNdBzFOx9RaC6gLGOsGUU5TXjdAru3eiNC6eiRHN3rFoO4GUJjYCRaCTWq4P0BGM6zXM4VSIFDo20SzQ80Eld_UYQwYA=', start_index=6294)
Annotation(end_index=7031, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEMmYxyuEPePyQ1p2DdGH4RqNSWLNHSryOuGXh2zEeEuRfMWsXqHQBk-9UDSEb_C4J2bAYhZWWf7Rj2UDk8u6XuZvNV0324NllVitbZyRPljFZ2i5aJswwNThjeoXlDXdVdmVosapw=', start_index=7017)
Annotation(end_index=7031, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHtq8aoCqKExb89FCMJzi66SEyjg7pEHJjHhGYbbDEFsMIrJP2QaViuXMW7rhZ8i77dFSV6LRK4_9GftKYlB913ptksedGnXY0dsEHyRQju0jVc4bdWgkgRV2t1HMbZZBRtAr3MzWfFcTAvopXOcPtvACn9RoUaeRkCahQqoA==', start_index=7017)
Annotation(end_index=7577, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQED7GE48S1WOZoFpuejRIc92iwq16wiDt7rZERzRXTicU_0u1fXFHRe1JCD7LD8ZFOxHhZALANVdtTSeu_pKOtyGvZ-OO9Ur3yN_Yb0utNpTRVlqLN0s0YaU-mnxnE1JLtkpPXgkjed33XVwwVk0tUuV0KOQ48BKukgUtD8lvRpagTmXQsl9Zu9mzXVvnM_tx-dhE16KBea9uyEbB3FbQBbwu2dm6HrCb8FHw==', start_index=7567)
Annotation(end_index=8581, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmzZFY9DLx1TWJ2-KuEJGM2mmj7T_XFQt0HsFAThH1B7d9EoNmlAGyojctD8X1EuDaHR1DGd3dziTgrIiEC2WrQTPbMtUzgushem-66236oPGAjV1XE0NRnZP15YeO1119pPSHwbM89AMYvEEOrc6U62caWiBRAuDS2qGVw47t2CvltyLppqbg7KDp_7SuLs9dPKqwxr1O8lQ=', start_index=8568)
Annotation(end_index=8581, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG_BNiaZ_BiP_IpbJ5AkpKUPZbbLN0KLRJU44rNZquboayTNdBzFOx9RaC6gLGOsGUU5TXjdAru3eiNC6eiRHN3rFoO4GUJjYCRaCTWq4P0BGM6zXM4VSIFDo20SzQ80Eld_UYQwYA=', start_index=8568)
Annotation(end_index=9059, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFqtmpTs-1LtCMEExBhTOcXGvWxvkHdFWSp5K63xvs0h6ZGgDrbzVN-LG5XYOhL1w1nsDsOpARwbg20D9haSU3caip36P4M4van_2ltIL5gNmxmFCFwWeqoEDzT-ODyzGkhU18aldKgYhZ9vEUk_7cIIdM3NjN3UQt69x6PDipsQYsyg9YKDqv8WbsXIq-2D09j2jwDOpw0N0M-ZJZw17gIO631TNrNgsGT3JMMXRqE-C9EirHafI23bd3qmvvO8jg=', start_index=9049)
Annotation(end_index=9343, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEyx6ylM7ficknZ1XetcZ0bA9det8CXMCWWfs00M88W5jMhPsozzihQMs4JbY3aA0mNQ6d3db3RcKhdKJK9ikYrU6eQ_M_EtLKEHtwfl_VJjuqaD9polfE5sWsDV0ctpBphVCX6YDgh8kOIJlLfy1W0mqQhwNiS6CFe_6Xy_XXnVGP38xnNB_W1MWPzijUjLa6x9-F1WnT5gT6sg05AOa0bZ7eqaFbx95m31w==', start_index=9333)
Annotation(end_index=9716, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEyx6ylM7ficknZ1XetcZ0bA9det8CXMCWWfs00M88W5jMhPsozzihQMs4JbY3aA0mNQ6d3db3RcKhdKJK9ikYrU6eQ_M_EtLKEHtwfl_VJjuqaD9polfE5sWsDV0ctpBphVCX6YDgh8kOIJlLfy1W0mqQhwNiS6CFe_6Xy_XXnVGP38xnNB_W1MWPzijUjLa6x9-F1WnT5gT6sg05AOa0bZ7eqaFbx95m31w==', start_index=9706)
Annotation(end_index=10070, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHqKu155n_JzPsxpDjQGmYDoYu_dQ_l91AEqLv_-4bV596p3_ItlokeWSVZ39QLmmOX87sI7aiDeehGyKued2L3aaHe_wKoetTv332726NoZhyZHPSX8IN3ccmShMUZwdvhqmHxemhYB-34hRkOS4QIA7eI7lZXATmai3kOJoDnvaBKDS17jUYPRt4FLKJFP0LGRbODJRL8YIPRAbkQKcTiVNHMm1Qf_Yi3wOuEoi9kIjcL0dir15mkWsetp7Z8E7aW', start_index=10060)
Annotation(end_index=10439, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEtdksKa0dUvs7kStF8tucfQ87VJYu3xdxYxhXkU6F0eTgexnTO7BU4V2zv0tNxtLY3U10BFB7ZIRkpgdwey4YJwjsttEqigSRorx1FoFrO9Q8S9HM1GjnyZnNwobyF6pLuqhOZcK6YJ1LAom2FGlb-X7GpuH5oq5rMaHWdqRfjzUC3mcEQXg1shJEQRwruTF2ugP8KjK4=', start_index=10425)
Annotation(end_index=10439, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHbLQbl12LRpEGi6I1NPwXo8HAygQvf-dfqTo0YWbTTAWchm4nGCqp0AQjRooDm1lL1nwDwc9PlTSEln4hiOyvj4bAsa4XlqnT1kYTBGpwg14fIJBID', start_index=10425)
Annotation(end_index=10779, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmzZFY9DLx1TWJ2-KuEJGM2mmj7T_XFQt0HsFAThH1B7d9EoNmlAGyojctD8X1EuDaHR1DGd3dziTgrIiEC2WrQTPbMtUzgushem-66236oPGAjV1XE0NRnZP15YeO1119pPSHwbM89AMYvEEOrc6U62caWiBRAuDS2qGVw47t2CvltyLppqbg7KDp_7SuLs9dPKqwxr1O8lQ=', start_index=10767)
Annotation(end_index=10779, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGAMzU2l0DUYqw9cBAFKIVhNBX2rpgRxRUf4WUCqF7lHHln0qzcvkUVp5YDyK5mv3UHrKM05l467Ae9_ijtePZz-lfLnz1TzkNF4wS3XnNownldOc_78C04GNqpuKZYIjjAkS0mk3FXBh7V2heMdQYKBEWkF2vE1ZaKC9IeX-NtRQilWzcLA3UrxO8FtZueD2XG6mgE8xUszTflmKoMK-s5G-ygW1OaX0XsBidJxto0-r8PqqWt3Y3M2z-ZXfPmgQDHQj496VqzD11amw==', start_index=10767)
Annotation(end_index=11976, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1RG-wmYnVcADD__S90f9uEHPdfkXPNUAm6E6xkjC5WuKrwwqL06o_K-cefrGOeKd2B6km9oDa0jAB7o3_S2vDMengr9UMnB3XtuTbU-STJ21KL8icQypFObqxolUaYFSMid5wgdP7UuM=', start_index=11963)
Annotation(end_index=11976, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGcR1diqfoZt22UFDiRqyV0UqADeAX5V_Y0d_HJZKgtrxJhJ0JJSRCdBTdGAj8cnavVwCNS0PvHSp8-xInGWYUJQtBL4sXzxwHEx9XD7v77_pkRN4LFL70HIn8Lzx5kXquppMikeE7NcA==', start_index=11963)
Annotation(end_index=12575, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1RG-wmYnVcADD__S90f9uEHPdfkXPNUAm6E6xkjC5WuKrwwqL06o_K-cefrGOeKd2B6km9oDa0jAB7o3_S2vDMengr9UMnB3XtuTbU-STJ21KL8icQypFObqxolUaYFSMid5wgdP7UuM=', start_index=12566)
Annotation(end_index=13685, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE6YSPXeL6JBiV4tjiNhkON0NeYXPOfJ7wfEwttF_rc_xqXSt2vN_RZv0sM4lt2BfWrSHFmcIQg8lRR39ECI2OoFiQTCXu95MBMR1CrzZmqb26OC8iH0qwtc_iOkKluc3fYLiy1', start_index=13673)
Annotation(end_index=13685, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEOIK1tydhWFMTbG6dAAmWJ-Nbs6aDVp0C3YJtxw1JvChC362qduW_ZqPqe86smEuhQeDL7ZdsoQyECSrsFizcRukc-Qmtj85RHu0gTXDNwlqjscITIujlhpDL2nhazmf7JRotRBwggLQ==', start_index=13673)
Annotation(end_index=14010, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQElIXNqcyfdqCMThhsQBzzTAWr9nTxu0XCSwqphUa2uOHkqfTJB67TLm8fp1ZQTNymBvzPLJ0DfBK1rWJbR9OrVzxsco-y4DnfhG_CvY4MXbfgZrvN5nwepSm-7RoVKYDgF1C-Vpk9n', start_index=13996)
Annotation(end_index=14010, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEtdksKa0dUvs7kStF8tucfQ87VJYu3xdxYxhXkU6F0eTgexnTO7BU4V2zv0tNxtLY3U10BFB7ZIRkpgdwey4YJwjsttEqigSRorx1FoFrO9Q8S9HM1GjnyZnNwobyF6pLuqhOZcK6YJ1LAom2FGlb-X7GpuH5oq5rMaHWdqRfjzUC3mcEQXg1shJEQRwruTF2ugP8KjK4=', start_index=13996)
Annotation(end_index=14459, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF8D3g-Ypz8qaH1BAjHKGpy5qiU6m0mXh0SyXMaC7nY0mc-Mok0mH020IKkYSFVJl9N68gf0qG9J6QpxSKKdkTROx6Gi9S4RkfKK0mR9_oo1qImSBC-nMZ0RjVTgI_3R3y4L1rFUXgJpA==', start_index=14445)
Annotation(end_index=14459, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH7zeaiexw1RJ4I07pyU_ueNkbZBihma1F7Z1_Ax12C6X_nAuQeHmk_muCzQ76KS38mEGIEQvgXmjfkmzksJiDih5dYON1wuDexNlFa5ULW2oXYgpcwe1LCTADM_SoWJfbsb4thr5fWftLmJav8rjXurVSyo8GD_db9K3eBLTU7DWJHAZ_4ZzqTTYadr9Yv7YXPbwLCrYA2b-jITuj0SN8bblGOnw==', start_index=14445)
Annotation(end_index=14807, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEfdMSaOt-CZtHFuJ5w8Q059tEeq_Q_pC51cTT5zGURl-Ybho1REB4JhQeghURGjvQ6MtBVT-SxxsReO_Zq8hSenMjY0m12HRy_PtLhBjwYCozuTxPQwXgFe85HHSfej7LoWJJKme7egg==', start_index=14797)
Annotation(end_index=15483, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEHJnqxSCjRMIC31h4Aip_tLZCkozyoCUv37MSMDjLjChpxlpBwPCR2YIEXVNR8FdK2Mws3OeG2zyuQh89IWB2juBuWG6W17hSyWLW0yiM7hVeJCGZRCrQUbBuLiLOTdLiRV3Kq_8ZOz27fW32kEg4=', start_index=15469)
Annotation(end_index=15483, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH1hPnCcTjKGai9TTP1dUrAZ7AORiIILYXufn8OuZurPf_wYkBRxrjjzLMjxs0K-PwsnxRN33r8HtK4omi8VLMpUY5NW7G0TT_2SxFcOyt2WuUwwPXqhwS5ji9JFXJ7xVwsmUhjrNyBmbZzk1Fud5uF_hSRBdWuq_jI7oopUs621ivuVhH0EXmJVRccLLtn9sA=', start_index=15469)
Annotation(end_index=15932, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF0kdyg_zgdzzAA2MomPjHnsPdBV1zcT5bKs1UHnPFM9nATkLZnrOtTvdXAil5A-vuzL3D8AzmOd8uUObSUlpCizYXyeU1wzfY1PruTSuWpJ4rW7eBLJq3W2yIuRrI=', start_index=15923)
Annotation(end_index=16323, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF0kdyg_zgdzzAA2MomPjHnsPdBV1zcT5bKs1UHnPFM9nATkLZnrOtTvdXAil5A-vuzL3D8AzmOd8uUObSUlpCizYXyeU1wzfY1PruTSuWpJ4rW7eBLJq3W2yIuRrI=', start_index=16310)
Annotation(end_index=16323, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHqKu155n_JzPsxpDjQGmYDoYu_dQ_l91AEqLv_-4bV596p3_ItlokeWSVZ39QLmmOX87sI7aiDeehGyKued2L3aaHe_wKoetTv332726NoZhyZHPSX8IN3ccmShMUZwdvhqmHxemhYB-34hRkOS4QIA7eI7lZXATmai3kOJoDnvaBKDS17jUYPRt4FLKJFP0LGRbODJRL8YIPRAbkQKcTiVNHMm1Qf_Yi3wOuEoi9kIjcL0dir15mkWsetp7Z8E7aW', start_index=16310)
Annotation(end_index=16801, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1RG-wmYnVcADD__S90f9uEHPdfkXPNUAm6E6xkjC5WuKrwwqL06o_K-cefrGOeKd2B6km9oDa0jAB7o3_S2vDMengr9UMnB3XtuTbU-STJ21KL8icQypFObqxolUaYFSMid5wgdP7UuM=', start_index=16792)
Annotation(end_index=17143, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1RG-wmYnVcADD__S90f9uEHPdfkXPNUAm6E6xkjC5WuKrwwqL06o_K-cefrGOeKd2B6km9oDa0jAB7o3_S2vDMengr9UMnB3XtuTbU-STJ21KL8icQypFObqxolUaYFSMid5wgdP7UuM=', start_index=17134)
Annotation(end_index=17578, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1RG-wmYnVcADD__S90f9uEHPdfkXPNUAm6E6xkjC5WuKrwwqL06o_K-cefrGOeKd2B6km9oDa0jAB7o3_S2vDMengr9UMnB3XtuTbU-STJ21KL8icQypFObqxolUaYFSMid5wgdP7UuM=', start_index=17565)
Annotation(end_index=17578, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHfonUhG1Yc8ZVfB2f4hV6Ewyfoprk_LRio_zmINVAhxshSder8DAeDCX2aEw67VjwF0CPAVInNDGS7dFyFyhbivnPQDoIbHNR_IWzkVg6oaBukpEqUzc5-QMoyEPa0KSM6mhhMR6GvRCo3', start_index=17565)
Annotation(end_index=18601, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEHJnqxSCjRMIC31h4Aip_tLZCkozyoCUv37MSMDjLjChpxlpBwPCR2YIEXVNR8FdK2Mws3OeG2zyuQh89IWB2juBuWG6W17hSyWLW0yiM7hVeJCGZRCrQUbBuLiLOTdLiRV3Kq_8ZOz27fW32kEg4=', start_index=18591)
Annotation(end_index=18689, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFqtmpTs-1LtCMEExBhTOcXGvWxvkHdFWSp5K63xvs0h6ZGgDrbzVN-LG5XYOhL1w1nsDsOpARwbg20D9haSU3caip36P4M4van_2ltIL5gNmxmFCFwWeqoEDzT-ODyzGkhU18aldKgYhZ9vEUk_7cIIdM3NjN3UQt69x6PDipsQYsyg9YKDqv8WbsXIq-2D09j2jwDOpw0N0M-ZJZw17gIO631TNrNgsGT3JMMXRqE-C9EirHafI23bd3qmvvO8jg=', start_index=18679)
Annotation(end_index=18777, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEMmYxyuEPePyQ1p2DdGH4RqNSWLNHSryOuGXh2zEeEuRfMWsXqHQBk-9UDSEb_C4J2bAYhZWWf7Rj2UDk8u6XuZvNV0324NllVitbZyRPljFZ2i5aJswwNThjeoXlDXdVdmVosapw=', start_index=18767)
Annotation(end_index=18854, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHtq8aoCqKExb89FCMJzi66SEyjg7pEHJjHhGYbbDEFsMIrJP2QaViuXMW7rhZ8i77dFSV6LRK4_9GftKYlB913ptksedGnXY0dsEHyRQju0jVc4bdWgkgRV2t1HMbZZBRtAr3MzWfFcTAvopXOcPtvACn9RoUaeRkCahQqoA==', start_index=18844)
Annotation(end_index=18937, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEOIK1tydhWFMTbG6dAAmWJ-Nbs6aDVp0C3YJtxw1JvChC362qduW_ZqPqe86smEuhQeDL7ZdsoQyECSrsFizcRukc-Qmtj85RHu0gTXDNwlqjscITIujlhpDL2nhazmf7JRotRBwggLQ==', start_index=18928)
Annotation(end_index=19017, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF0kdyg_zgdzzAA2MomPjHnsPdBV1zcT5bKs1UHnPFM9nATkLZnrOtTvdXAil5A-vuzL3D8AzmOd8uUObSUlpCizYXyeU1wzfY1PruTSuWpJ4rW7eBLJq3W2yIuRrI=', start_index=19008)
Annotation(end_index=19080, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFWnYGWMoMngkc3X6KN9C2BkuKIXy7pI1UK63k0150VSavTSYkxzlyZTtqKPJp6OdXvINFCkUqp0uNJP75cilvD3pvQeRuKDNpOVAVUoFWYzLo3fgzC2riUtnleMOOP484u4ffIGP5IO6hZuYR1dSdNsJmB0p5JMaDUum3I-IWGZbNQyXOtQMDAQqzWIbB51ULoqIxd5kPxzoFjMOwsjKhIma2l1loAGRac7pZiHiyzADu1os5aWPo=', start_index=19071)
Annotation(end_index=19168, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1RG-wmYnVcADD__S90f9uEHPdfkXPNUAm6E6xkjC5WuKrwwqL06o_K-cefrGOeKd2B6km9oDa0jAB7o3_S2vDMengr9UMnB3XtuTbU-STJ21KL8icQypFObqxolUaYFSMid5wgdP7UuM=', start_index=19159)
Annotation(end_index=19244, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmzZFY9DLx1TWJ2-KuEJGM2mmj7T_XFQt0HsFAThH1B7d9EoNmlAGyojctD8X1EuDaHR1DGd3dziTgrIiEC2WrQTPbMtUzgushem-66236oPGAjV1XE0NRnZP15YeO1119pPSHwbM89AMYvEEOrc6U62caWiBRAuDS2qGVw47t2CvltyLppqbg7KDp_7SuLs9dPKqwxr1O8lQ=', start_index=19235)
Annotation(end_index=19340, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEtdksKa0dUvs7kStF8tucfQ87VJYu3xdxYxhXkU6F0eTgexnTO7BU4V2zv0tNxtLY3U10BFB7ZIRkpgdwey4YJwjsttEqigSRorx1FoFrO9Q8S9HM1GjnyZnNwobyF6pLuqhOZcK6YJ1LAom2FGlb-X7GpuH5oq5rMaHWdqRfjzUC3mcEQXg1shJEQRwruTF2ugP8KjK4=', start_index=19330)
Annotation(end_index=19445, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHbLQbl12LRpEGi6I1NPwXo8HAygQvf-dfqTo0YWbTTAWchm4nGCqp0AQjRooDm1lL1nwDwc9PlTSEln4hiOyvj4bAsa4XlqnT1kYTBGpwg14fIJBID', start_index=19435)
Annotation(end_index=19505, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE4IhyO9SXQj8YS8GcxooyEqH3-jFZnvRREkjDBBCJPNRuwxawxvKFqj8aQCnQ03CfUYAieUTu_Sa6AGs_ZncBcEQE9R98CspJveyRHJ-4TBGuTduX4tp2bntcEr20wmuBOEwU-Gb9mI4cJAhxiJdlTUrviPK4ccHRDzC5VCHQo4PW4Buz_ulnCN1aylHRa3h6NvdQI6d-wrcRt_ai1H_eRE4nBdG6zWxCrspw82wNyq17wf5XD-9bdR_K8Rw9_TM-stwc6ww9O', start_index=19496)
Annotation(end_index=19596, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH1hPnCcTjKGai9TTP1dUrAZ7AORiIILYXufn8OuZurPf_wYkBRxrjjzLMjxs0K-PwsnxRN33r8HtK4omi8VLMpUY5NW7G0TT_2SxFcOyt2WuUwwPXqhwS5ji9JFXJ7xVwsmUhjrNyBmbZzk1Fud5uF_hSRBdWuq_jI7oopUs621ivuVhH0EXmJVRccLLtn9sA=', start_index=19586)
Annotation(end_index=19676, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHqKu155n_JzPsxpDjQGmYDoYu_dQ_l91AEqLv_-4bV596p3_ItlokeWSVZ39QLmmOX87sI7aiDeehGyKued2L3aaHe_wKoetTv332726NoZhyZHPSX8IN3ccmShMUZwdvhqmHxemhYB-34hRkOS4QIA7eI7lZXATmai3kOJoDnvaBKDS17jUYPRt4FLKJFP0LGRbODJRL8YIPRAbkQKcTiVNHMm1Qf_Yi3wOuEoi9kIjcL0dir15mkWsetp7Z8E7aW', start_index=19666)
Annotation(end_index=19744, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEyx6ylM7ficknZ1XetcZ0bA9det8CXMCWWfs00M88W5jMhPsozzihQMs4JbY3aA0mNQ6d3db3RcKhdKJK9ikYrU6eQ_M_EtLKEHtwfl_VJjuqaD9polfE5sWsDV0ctpBphVCX6YDgh8kOIJlLfy1W0mqQhwNiS6CFe_6Xy_XXnVGP38xnNB_W1MWPzijUjLa6x9-F1WnT5gT6sg05AOa0bZ7eqaFbx95m31w==', start_index=19734)
Annotation(end_index=19824, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHPSm_HDTP6wqI767e01X1iBAUsuBgSjQI_hajuekNJO4RIq7XuOVctZbaeLt6IB7RHlm9icm367zgAkQroXv8zsXmtbVBkdoi_v_-ounDSWSsnLjldaV9CrONRbEyNUxEzOgfpulr71f5l_xvSr0UkAP_Gjuho5ygY4LJi2RV-kS-0-tshxR4BnOF_rhfiNlPQLcrx2_Ew13FbkuzMit5zVletoskT2N0AfXKFQUYZZXPtaOGNtB6h-6pScRd3hkp0-fuAeCwjKg==', start_index=19814)
Annotation(end_index=19913, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGcR1diqfoZt22UFDiRqyV0UqADeAX5V_Y0d_HJZKgtrxJhJ0JJSRCdBTdGAj8cnavVwCNS0PvHSp8-xInGWYUJQtBL4sXzxwHEx9XD7v77_pkRN4LFL70HIn8Lzx5kXquppMikeE7NcA==', start_index=19903)
Annotation(end_index=19993, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQED7GE48S1WOZoFpuejRIc92iwq16wiDt7rZERzRXTicU_0u1fXFHRe1JCD7LD8ZFOxHhZALANVdtTSeu_pKOtyGvZ-OO9Ur3yN_Yb0utNpTRVlqLN0s0YaU-mnxnE1JLtkpPXgkjed33XVwwVk0tUuV0KOQ48BKukgUtD8lvRpagTmXQsl9Zu9mzXVvnM_tx-dhE16KBea9uyEbB3FbQBbwu2dm6HrCb8FHw==', start_index=19983)
Annotation(end_index=20070, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE6YSPXeL6JBiV4tjiNhkON0NeYXPOfJ7wfEwttF_rc_xqXSt2vN_RZv0sM4lt2BfWrSHFmcIQg8lRR39ECI2OoFiQTCXu95MBMR1CrzZmqb26OC8iH0qwtc_iOkKluc3fYLiy1', start_index=20061)
Annotation(end_index=20143, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEfdMSaOt-CZtHFuJ5w8Q059tEeq_Q_pC51cTT5zGURl-Ybho1REB4JhQeghURGjvQ6MtBVT-SxxsReO_Zq8hSenMjY0m12HRy_PtLhBjwYCozuTxPQwXgFe85HHSfej7LoWJJKme7egg==', start_index=20133)
Annotation(end_index=20206, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1RG-wmYnVcADD__S90f9uEHPdfkXPNUAm6E6xkjC5WuKrwwqL06o_K-cefrGOeKd2B6km9oDa0jAB7o3_S2vDMengr9UMnB3XtuTbU-STJ21KL8icQypFObqxolUaYFSMid5wgdP7UuM=', start_index=20197)
Annotation(end_index=20275, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGAMzU2l0DUYqw9cBAFKIVhNBX2rpgRxRUf4WUCqF7lHHln0qzcvkUVp5YDyK5mv3UHrKM05l467Ae9_ijtePZz-lfLnz1TzkNF4wS3XnNownldOc_78C04GNqpuKZYIjjAkS0mk3FXBh7V2heMdQYKBEWkF2vE1ZaKC9IeX-NtRQilWzcLA3UrxO8FtZueD2XG6mgE8xUszTflmKoMK-s5G-ygW1OaX0XsBidJxto0-r8PqqWt3Y3M2z-ZXfPmgQDHQj496VqzD11amw==', start_index=20266)
Annotation(end_index=20349, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmzZFY9DLx1TWJ2-KuEJGM2mmj7T_XFQt0HsFAThH1B7d9EoNmlAGyojctD8X1EuDaHR1DGd3dziTgrIiEC2WrQTPbMtUzgushem-66236oPGAjV1XE0NRnZP15YeO1119pPSHwbM89AMYvEEOrc6U62caWiBRAuDS2qGVw47t2CvltyLppqbg7KDp_7SuLs9dPKqwxr1O8lQ=', start_index=20340)
Annotation(end_index=20427, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG_BNiaZ_BiP_IpbJ5AkpKUPZbbLN0KLRJU44rNZquboayTNdBzFOx9RaC6gLGOsGUU5TXjdAru3eiNC6eiRHN3rFoO4GUJjYCRaCTWq4P0BGM6zXM4VSIFDo20SzQ80Eld_UYQwYA=', start_index=20417)
Annotation(end_index=20497, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGfrpmWLFTr0Nbj3XXibKTA5atuBidZbZP3OaBKZCxtgNqO4SDsb9PDCDMl7OWMvMezUwXPwFYZTZYsBGNtkhqgBy6_PO7euP_1vCqi13QYWq3SAQAzdP7WrQHl09WmVi609IGd1eqV', start_index=20488)
Annotation(end_index=20568, source='https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH7zeaiexw1RJ4I07pyU_ueNkbZBihma1F7Z1_Ax12C6X_nAuQeHmk_muCzQ76KS38mEGIEQvgXmjfkmzksJiDih5dYON1wuDexNlFa5ULW2oXYgpcwe1LCTADM_SoWJfbsb4thr5fWftLmJav8rjXurVSyo8GD_db9K3eBLTU7DWJHAZ_4ZzqTTYadr9Yv7YXPbwLCrYA2b-jITuj0SN8bblGOnw==', start_index=20558)

## Sources
